HSPG2 and schizophrenia: The GWAS included 100 Japanese schizophrenia patients (50 with treatment-resistant TD) and the findings were validated in an independent cohort of 172 patients (36 with treatment-resistant TD), identifying an association between several polymorphisms in the HSPG2 gene and TD (Arinami and Inada 2011).